Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross‐over trial

Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross‐over trial AbbreviationsFEV1forced expiratory volume in 1 sFVCforced vital capacityNHFnasal high flowNIVnon‐invasive ventilationPaCO2partial pressure of arterial carbon dioxidePtCO2transcutaneous partial pressure of carbon dioxideRIPRespiratory Inductance PlethysmographyStO2transcutaneous oxygen saturationINTRODUCTIONIn acute exacerbations of COPD, hypercapnia is associated with worse clinical outcomes including death. Non‐invasive ventilation (NIV) is recommended to provide respiratory support to patients with exacerbations of COPD who have hypercapnic respiratory failure despite optimal medical therapy. Tolerability of NIV may be a barrier to effective use and an alternative to NIV is a priority for the management of acute exacerbations of COPD.Nasal high flow (NHF) therapy may cause a modest reduction in the partial pressure of arterial carbon dioxide (PaCO2) in both stable and acute COPD. However, the interpretation of studies of NHF, and their applicability to clinical practice, remains variably limited by the confounding effect of concomitant oxygen therapy, absence of randomized controlled treatments and a lack of data on the dose–response relationship across the range of flows used in clinical practice.The present study is a randomized controlled cross‐over trial of the effect of three different flow rates of NHF therapy compared with a control intervention of room air, in patients with stable COPD who do not need concomitant oxygen therapy. The http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Respirology Wiley

Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross‐over trial

Loading next page...
 
/lp/wiley/nasal-high-flow-therapy-and-ptco2-in-stable-copd-a-randomized-GlF0mj4ZhP
Publisher
Wiley
Copyright
© 2018 Asian Pacific Society of Respirology
ISSN
1323-7799
eISSN
1440-1843
D.O.I.
10.1111/resp.13185
Publisher site
See Article on Publisher Site

Abstract

AbbreviationsFEV1forced expiratory volume in 1 sFVCforced vital capacityNHFnasal high flowNIVnon‐invasive ventilationPaCO2partial pressure of arterial carbon dioxidePtCO2transcutaneous partial pressure of carbon dioxideRIPRespiratory Inductance PlethysmographyStO2transcutaneous oxygen saturationINTRODUCTIONIn acute exacerbations of COPD, hypercapnia is associated with worse clinical outcomes including death. Non‐invasive ventilation (NIV) is recommended to provide respiratory support to patients with exacerbations of COPD who have hypercapnic respiratory failure despite optimal medical therapy. Tolerability of NIV may be a barrier to effective use and an alternative to NIV is a priority for the management of acute exacerbations of COPD.Nasal high flow (NHF) therapy may cause a modest reduction in the partial pressure of arterial carbon dioxide (PaCO2) in both stable and acute COPD. However, the interpretation of studies of NHF, and their applicability to clinical practice, remains variably limited by the confounding effect of concomitant oxygen therapy, absence of randomized controlled treatments and a lack of data on the dose–response relationship across the range of flows used in clinical practice.The present study is a randomized controlled cross‐over trial of the effect of three different flow rates of NHF therapy compared with a control intervention of room air, in patients with stable COPD who do not need concomitant oxygen therapy. The

Journal

RespirologyWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off